LAP IA 60 aligns, closes and staples the common opening for intracorporeal anastomosis quickly and securely.
Illumina will develop and integrate NGS-based protein identification and measurement tools in laboratories globally.
The new, minimally invasive blood test can detect cancer in patients with non-specific symptoms.
The regulator will analyse information received from retailers, suppliers and the public.
Found in human platelets, the cellular biomarker can track the extent of depression in individual patients.
Give your business an edge with our leading industry insights.
RemeOs trauma screw is designed to fix bone fractures as well as after osteotomies.
Initial lab results had shown COVISTIX could identify Omicron N protein at a significantly lower level than other tests.
The test detects nucleocapsid protein of SARS-CoV-2 and provides results in 20 minutes for all Covid-19 variants, including Omicron.
The acquisition will expand Labcorp’s next-generation sequencing-based genomic profiling capabilities.
The Genedrive COV19-ID assay met the current requirements from the MHRA in the UK for point-of-care SARS-CoV-2 molecular tests.